PKM and neoplasm: By inhibiting the encoding of E-cadherin and increasing the nuclear transcription of signal transducer and activator of Transcription 3 (STAT3), Dimer PKM2 can lead to a loss of EMT in tumour cells and promote tumour cell invasion and migration [181,182].